Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Privia Health Group (PRVA)

Privia Health Elects Dr. Opella Ernest to Board, Effective September 1, 2026

Neutral Impact 2 of 5 leadership Written later

Privia Health Group's board elected Opella Ernest, M.D., a former HCSC executive, as a Class III director effective September 1, 2026, and named her to the Compliance Committee. The change adds a director to the board and carries a $200,000 grant-date value equity award, but the filing does not describe any financial results or operational impact.

Key points

  • Dr. Ernest was elected by the board on August 12, 2026, effective September 1, 2026.
  • She was appointed to the Compliance Committee effective September 1, 2026.
  • Non-employee director pay includes an annual cash retainer and restricted stock units with a $200,000 grant-date fair market value.
  • Dr. Ernest is currently President, HCSC Markets at Health Care Service Corporation, a role held since 2023.

The filing

CompanyPrivia Health Group (PRVA)
Form8-K, current report
Filed with the SECAug 18, 2026, 9:03 AM ET
Accession number0001759655-26-000068

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 18, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.